Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

3 Biotech Buyout Candidates for 2012
Motley Fool
Tuesday, January 31, 2012 - 8:00am
tags:
Vertex Pharmaceuticals, ONYX Pharmaceuticals, Acorda, Biogen Idec, GSK, Novartis, Bayer, Pfizer, Teva Pharmaceuticals, Merck, JNJ
FDA Pharma Meetings for February
Motley Fool
Tuesday, January 31, 2012 - 7:58am
tags:
FDA, Amgen, Xgeva, Cell Therapeutics, Pixuvri, Vivus, Qnexa, Chelsea Therapeutics, Northera
Allos Therapeutics asks EU advisory panel to reconsider negative opinion on lymphoma drug
Yahoo/AP
Tuesday, January 31, 2012 - 7:56am
tags:
Allos, Europe, lymphoma, Folotyn
Pfizer 4Q net falls by half after generic Lipitor
Yahoo/AP
Tuesday, January 31, 2012 - 7:50am
tags:
earnings, Lipitor, Pfizer
Orexo Falls as Much as 20% After J&J Drug Research Deal Canceled
Bloomberg
Tuesday, January 31, 2012 - 7:49am
tags:
Orexo, JNJ
Glaxo, Lilly, Pfizer Said to Be Interested in Turkey’s MN Pharma
Bloomberg
Tuesday, January 31, 2012 - 7:48am
tags:
GSK, Eli Lilly, Pfizer, Turkey, MN Pharma, M&A, Mustafa Nevzat, Mylan, Abbott Laboratories
Dendreon's Provenge And JNJ's Zytiga Both Had Strong Early Sales
Seeking Alpha
Tuesday, January 31, 2012 - 7:47am
tags:
Dendreon, Provenge, prostate cancer, JNJ, Zytiga
Expecting Catalyst Action For Astex Pharmaceuticals
Seeking Alpha
Tuesday, January 31, 2012 - 7:42am
tags:
Astex, Dacogen, small molecule drugs
Eli Lilly net income falls 27% as patents expire
Marketwatch
Tuesday, January 31, 2012 - 7:41am
tags:
earnings, Eli Lilly
J&J to replace Tylenol unit management: report
Yahoo/AP
Tuesday, January 31, 2012 - 7:33am
tags:
JNJ, Tylenol, recalls, McNeil
FDA nod fuels Bydureon vs. Victoza bout
Fierce Pharma
Monday, January 30, 2012 - 4:00pm
tags:
Victoza, diabetes, Bydureon, FDA, Amylin, Novo Nordisk, Alkermes
GTx soars after Citigroup predicts drug trial results will be positive
The Fly on the Wall
Monday, January 30, 2012 - 3:58pm
tags:
GTx, ostarine
FDA Approves Roche, Curis Skin-Cancer Drug
TheStreet.com
Monday, January 30, 2012 - 3:57pm
tags:
Curis, Roche, FDA, skin cancer, Erivedge
Earnings Preview: Biogen
Yahoo/Zacks
Monday, January 30, 2012 - 3:54pm
tags:
earnings, Biogen Idec
What the Roche Bid for Illumina Tells Us About the Future of Genomics
Forbes
Monday, January 30, 2012 - 3:53pm
tags:
Roche, M&A, Illumina, genomics
Gilead Sciences Inc. Fourth Quarter Earnings Sneak Peek
Yahoo/Wall St Cheat Sheet
Monday, January 30, 2012 - 3:51pm
tags:
Gilead, earnings
IPO Preview: Merrimack Pharmaceuticals
Seeking Alpha
Monday, January 30, 2012 - 3:51pm
tags:
IPOs, Merrimack Pharmaceuticals, cancer, Sanofi, MM-121
Reason To Track Astex And Adeona
Seeking Alpha
Monday, January 30, 2012 - 3:50pm
tags:
Astex, Adeona
AstraZeneca May Shed Thousands More Jobs
Pharmalot
Monday, January 30, 2012 - 12:08pm
tags:
layoffs, AstraZeneca
Forbes Earnings Preview: Allergan
Forbes
Monday, January 30, 2012 - 12:07pm
tags:
Allergan, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.